Kymera Therapeutics

Kymera Appoints Ellen Chiniara, J.D., as Chief Legal Officer and Corporate Secretary

WATERTOWN, Mass., Jan. 04, 2023 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing targeted protein degradation (TPD) to deliver novel small molecule protein degrader medicines, today announced the appointment of Ellen Chiniara, J.D.,